ലിവർഡോക് (The Liver Doc)

Gut health scammers, fake alternative medicine “autism experts,” and unscientific probiotic sellers often use fear and confusion to sell expensive products and treatments that lack real scientific evidence. They may claim that autism is caused by “toxins” in the gut or that special diets, detox plans, or probiotic supplements can cure complex conditions, even though these claims are not supported by credible research. By using impressive-sounding language, testimonials, and social media marketing, they can appear trustworthy while promoting misleading or false information. This kind of fraud not only wastes money but can also delay proper medical care and spread harmful myths about health and development. Check for credentials of those who claim to be "gut health" experts. Some examples of my publications on gut microbiome and liver diseases: Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease — Review on gut microbiota and liver conditions. 🔗 PubMed (2020): https://pubmed.ncbi.nlm.nih.gov/32274349/ Gut Microbiome and Alcohol-associated Liver Disease — Review detailing gut microbiota changes in alcohol-related liver disease. 🔗 PubMed (2022): https://pubmed.ncbi.nlm.nih.gov/36157139/ The role of gut microbiota in clinical complications, disease severity, and treatment response in severe alcoholic hepatitis — Clinical research on gut microbiota and alcoholic hepatitis. 🔗 PubMed (2022): https://pubmed.ncbi.nlm.nih.gov/34989986/ Significant gut microbiota related to patterns of drinking and alcohol relapse in patients with alcoholic hepatitis undergoing stool transplant or corticosteroid therapy — Study linking gut microbiota patterns with clinical outcomes. 🔗 PubMed (2023): https://pubmed.ncbi.nlm.nih.gov/37548864/ Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection — Research involving microbiota profiling in liver disease. 🔗 PubMed (2023): https://pubmed.ncbi.nlm.nih.gov/36406325/ Clinical outcomes and gut microbiota analysis of severe alcohol-associated hepatitis patients undergoing healthy donor fecal transplant or pentoxifylline therapy: single-center experience from Kerala — Clinical outcomes and microbiota analysis. 🔗 PubMed (2022): https://pubmed.ncbi.nlm.nih.gov/36479155/ Clinical outcomes and associated bacterial and fungal microbiota changes after high dose probiotic therapy for severe alcohol-associated hepatitis: An observational study — Observational study on probiotic therapy and microbiota effects. 🔗 PubMed (2024): https://pubmed.ncbi.nlm.nih.gov/39533632/ TheLiverDoc channel aims to provide the latest updates from scientific literature, through simple, easily understandable discussions, regarding general healthcare practices as well as those specifically related to liver disease. Follow TheLiverDoc Twitter (now boringly called X) - / theliverdr Instagram - / theliverdr This video is fundamentally based on: Article 51A[h] of The Constitution of India: It shall be the duty of every citizen of India to develop the scientific temper, humanism, and the spirit of inquiry and reform. Host: Dr. Abby Philips M.D., D.M (Senior Consultant and Clinical Scientist, Hepatology) at Rajagiri Hospital, Aluva, Cochin, Kerala, India Email: theliverdr@gmail.com or abbyphilips@theliverinst.in 'The Liver Doc' logo by Yeh! (Indonesia) 'The Liver Doc' logo animation by Navas (Kochi) Footage by Dr. Abby Philips, shot on Panasonic Lumix S5